Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 24:12:730167.
doi: 10.3389/fpsyt.2021.730167. eCollection 2021.

Effects of Appearance- and Performance-Enhancing Drugs on Personality Traits

Affiliations
Review

Effects of Appearance- and Performance-Enhancing Drugs on Personality Traits

Simona Zaami et al. Front Psychiatry. .

Abstract

Appearance- and performance-enhancing drugs (APEDs) are commonly used by adolescents and young adults in an effort to improve not only athletic performance but also physical and mental efficiency and sexual appearance. The rationale for using these drugs is grounded in the perceived importance of external appearance, the quest for health and youth, and the urge to boost one's sexual performances. Although APED users tend to be quite moderate overall, some specific subpopulations can display pathological use associated with high-risk behaviors. A wide and diverse range of APEDs is now easily accessible to almost anyone through backdoor online avenues. Common APEDs include anabolic-androgenic steroids, non-steroidal anabolics, anorectics, diuretics and ergo/thermogenics, nootropics or "cognition enhancers," licit and illicit psychostimulants, and finally, sexual enhancers. The use of APEDs appears linked to several psychopathological disorders of unclear prevalence, e.g., body image disorders and eating disorders, perfectionism, but also depression and loneliness. The role of personality traits related to APED use has been investigated in adolescents and young adults, in elite and amateur athletes, and in chemsexers and associated with the above-reported personality traits. The studies herein analyzed show that APED consumption in the general population is quickly growing into a public health concern. It is therefore essential to launch prevention and intervention projects aimed at promoting safe instrumental use of the body, not only in sports disciplines but also among the general population, and to promote psychological aid procedures for people with substance use issues, depression and anxiety, and body image disorders.

Keywords: APEDs; anabolic–androgenic steroids; appearance- and performance-enhancing drugs; personality traits; psychiatric implication.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The reviewer SP declared a shared affiliation with one the authors AM at the time of the review and past co-authorship/collaboration with one or more authors AM, SZ, and EM.

Similar articles

Cited by

References

    1. Hildebrandt T, Lai JK, Langenbucher JW, Schneider M, Yehuda R, Pfaff DW. The diagnostic dilemma of pathological appearance and performance enhancing drug use. Drug Alcohol Depend. (2011) 114:1–11. 10.1016/j.drugalcdep.2010.09.018 - DOI - PMC - PubMed
    1. Busardò FP, Frati P, Sanzo MD, Napoletano S, Pinchi E, Zaami S, et al. . The impact of nandrolone decanoate on the central nervous system. Curr Neuropharmacol. (2015) 13:122–31. 10.2174/1570159X13666141210225822 - DOI - PMC - PubMed
    1. Patanè FG, Liberto A, Maria Maglitto AN, Malandrino P, Esposito M, Amico F, et al. . Nandrolone decanoate: use, abuse and side effects. Medicina (Kaunas). (2020) 56:606. 10.3390/medicina56110606 - DOI - PMC - PubMed
    1. Zaami S, Busardò FP, Pichini S, Pacifici R, Marinelli E. The value of toxicological and forensic analyses in the global challenge to health risks caused by new psychoactive substances. Eur Rev Med Pharmacol Sci. (2019) 23:6008–10. 10.26355/eurrev_201907_18409 - DOI - PubMed
    1. Albertson TE, Chenoweth JA, Colby DK, Sutter ME. The changing drug culture: use and misuse of cognition-enhancing drugs. FP Essent. (2016) 441:25–9. - PubMed

LinkOut - more resources